| abstract |
The present invention relates to the use of 6- (3-aza-bicyclo [3.1.0] hex-3-yl) -2-phenyl-pyrimidine derivatives and platelet aggregation in humans and other mammals, including thrombosis The treatment and / or prevention of peripheral vascular, visceral vascular, hepatic vascular, renal vascular, cardiovascular and cerebrovascular diseases or disorders associated with vascular endothelial growth factor (VEGF) as P2Y 12 receptor antagonists (receptor antagonist) in relationship to their use. |